Abstract
Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well-being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 85-92 |
| Number of pages | 8 |
| Journal | Journal of Surgical Oncology |
| Volume | 120 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 1 2019 |
Fingerprint
Keywords
- cancer
- financial burden
- financial distress
- financial hardship
- financial toxicity
ASJC Scopus subject areas
- Surgery
- Oncology
Cite this
}
Financial toxicity in cancer care : Prevalence, causes, consequences, and reduction strategies. / Lentz, Robert; Benson III, Al B; Kircher, Sheetal Mehta.
In: Journal of Surgical Oncology, Vol. 120, No. 1, 01.07.2019, p. 85-92.Research output: Contribution to journal › Review article
TY - JOUR
T1 - Financial toxicity in cancer care
T2 - Prevalence, causes, consequences, and reduction strategies
AU - Lentz, Robert
AU - Benson III, Al B
AU - Kircher, Sheetal Mehta
PY - 2019/7/1
Y1 - 2019/7/1
N2 - Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well-being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.
AB - Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well-being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.
KW - cancer
KW - financial burden
KW - financial distress
KW - financial hardship
KW - financial toxicity
UR - http://www.scopus.com/inward/record.url?scp=85060163595&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060163595&partnerID=8YFLogxK
U2 - 10.1002/jso.25374
DO - 10.1002/jso.25374
M3 - Review article
C2 - 30650186
AN - SCOPUS:85060163595
VL - 120
SP - 85
EP - 92
JO - Journal of Surgical Oncology
JF - Journal of Surgical Oncology
SN - 0022-4790
IS - 1
ER -